Purpose/Objective: The aim of this study is to compare the failure model between esophageal carcinoma patients receiving elective nodal prophylactic irradiation and involved-field irradiation, and to explore the reason of failure and influence factors of local recurrence. Materials and Methods: From January 2006 to December 2012,245 patients of esophageal carcinoma receiving definitive radiation therapy in our hospital were respectively analyzed. One hundred and twenty-six patients received elective nodal prophylactic irradiation(ENI),and the other 119 patients received involved-field irradiation(IFI).Failure patterns were analyzed after treatment and long-term follow up. Local regional failure included esophagus lesion remaining or relapse and regional lymph nodes recurrence. Distance metastases included distant organ metastases and distant lymph node metastases. Multivariate analysis was performed by the Cox proportional hazard model. Results: The 1,3 and 5 years loco-regional control rates of ENI group and IFI group were 72.5%,52.8%,50.6% and 58.4%,35.8%,21.9%(χ 2 =7.881,P=0.005) respectively. The 1,3,and 5 years overall survival rates of the ENI group and IFI group were 74.3%,44.2%,24.5% and 68.9%,27.6%,15.9% (χ 2 =1.903,P=0.168). In Cox multivariate analysis, clinical T stage, tumor location, different radiotherapy region were independent factors for the loco-regional control of all patients. One hundred and sixty-three patients developed failure after treatment and follow-up. Simple loco-regional failure was observed in 92 patients, alone distant metastases was observed in 36 patients, and both regional failure and distant metastases was observed in 35 patients. The 1,3,and 5 years total failure rates of ENI group and IFI group was 35.4%,62.5%,69.0% and 46.5%,71.5%,81.5% respectively (χ 2 =4.402,P=0.036). The 1,3,and 5 years loco-regional failure rates of ENI and IFI group were 29.9%,48.4%,50.0% and 39.6%,62.1%,71.4% respectively (χ 2 =8.638, P=0.003). Conclusions: The elective nodal prophylactic irradiation of esophageal carcinoma with receiving definitive treatment could reduce loco-regional failures and improve local control. Maybe in order to improve the long-term survival.
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